Gelonghui on October 31 | zhejiang shapuaisi pharmaceutical (603168.SH) rose more than 7% to 8.5 yuan, with a total market value of 3.2 billion yuan. The company's revenue in the first three quarters was 359.402 million yuan. Among them, the revenue in the third quarter was 122.5498 million yuan, an increase of 23.77% compared to the previous quarter; net income attributable to the parent company was -6.0384 million yuan, narrowing the loss compared to the previous quarter. The company continues to increase its investment in research and development, actively promoting the research and development of new products, and transforming research and development into a driving force for high-quality development. (Gelonghui)
A股异动 | 莎普爱思涨超7% Q3营收环比增23.77%
A-share unusual movement | zhejiang shapuaisi pharmaceutical rose more than 7%, Q3 revenue increased by 23.77% compared to the previous quarter.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated